JCI-accredited · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Assoc. Prof. Dr. Umut Dişel Internal Medicine

Assoc. Prof. Dr. Umut Dişel

✓ Medically verified profile
Internal Medicine

Assoc. Prof. Dr. Umut Dişel

✓ Medically verified profile
Languages: Turkish, EnglishOnline consultationAcibadem Adana Hospital · Adana
★★★★★ From 2,400+ verified Acibadem patient reviews
Assoc. Prof. Dr. Umut Dişel

Quick answer

Assoc. Prof. Dr. Umut Dişel is an Internal Medicine specialist at Acibadem Adana Hospital in Adana with 8+ years of experience.

He focuses on cholangiocarcinoma, advanced cancer-associated biliary obstruction, head and neck cancer, chemotherapy, cisplatin-based concurrent chemoradiotherapy, and managing treatment-related complications such as infusion reactions and medication-related toxicities. He consults in Turkish and English and offers online video consultation.

Profile

About Assoc. Prof. Dr. Umut Dişel

Assoc. Prof. Dr. Umut Dişel is an Internal Medicine specialist with 8 years of experience. His listed areas of expertise include cholangiocarcinoma, head and neck cancer, chemotherapy infusion reactions, bevacizumab-related osteonecrosis of the jaw, angiogenesis inhibitor-associated hypertension, capecitabine-induced hand-foot syndrome, fludarabine-associated pulmonary toxicity, and secondary malignancy after imatinib therapy.

Dr. Dişel graduated from Çukurova University Faculty of Medicine in 1995. He completed Internal Medicine at Çukurova University Faculty of Medicine in 2001 and Medical Oncology at Cukurova University Faculty of Medicine in 2005. He was awarded the rank of Associate Professor in Medical Oncology in 2017. Dr. Dişel joined Acibadem Health Group in 2018. He sees patients at Acibadem Adana Hospital in Adana, Türkiye.

The profile lists 2 professional bodies, among them the Medical Oncology Society and the Anatolian Medical Oncology Association.

The profile lists 10 publications dated between 2011 and 2012. Their subjects include biliary obstruction and cholangiocarcinoma, chemotherapy infusion reactions and treatment-associated toxicities, and cisplatin-based concurrent chemoradiotherapy in head and neck cancer. The listed work also includes a case report on bevacizumab-related osteonecrosis of the jaw.

Dr. Dişel speaks Turkish and English. Online consultation is available, allowing patients abroad to speak with the doctor before travelling.

Clinical Focus

Areas of Expertise

Conditions treated and procedures performed by this specialist.

CholangiocarcinomaAdvanced cancer-associated biliary obstructionHead and neck cancerChemotherapyCisplatin-based concurrent chemoradiotherapyChemotherapy infusion reactionsBevacizumab-related osteonecrosis of the jawAngiogenesis inhibitor-associated hypertensionCapecitabine-induced hand-foot syndromeFludarabine-associated pulmonary toxicitySecondary malignancy after imatinib therapy
Background

Education

  • 2017Medical Oncology / Associate Professor
  • 2005Cukurova University Faculty of Medicine Medical Oncology
  • 2001Çukurova University Faculty of Medicine Internal Medicine
  • 1995Cukurova University Faculty of Medicine
Career

Professional Experience

  • 2018Acibadem Health Group
Affiliations

Professional Memberships

  • Medical Oncology Society
  • Anatolian Medical Oncology Association
Research

Selected Publications

  • Which patients with advanced cancer and biliary obstruction benefit from biliary stenting most? An analysis of prognostic factors Supportive Care in Cancer, 21(4), 1131-1135., Number of Citation: 2, Doi: 10.1007/s00520-012-1636-z ABALI HÜSEYİN,SEZER AHMET.Oğuzkurt Levent.GUREL KAMİL,Özkan Uğur.Beşen Ali Ayberk, SÜMBÜL AHMET TANER,KÖSE FATİH,DİŞEL UMUT
  • Acute infusion reactions to chemotherapeutic drugs: A single institute experience. JOURNAL OF BALKAN UNION OF ONCOLOGY, 18(1), 261-267., Number of Citation: 1, (Control No: 1606723) MUALLAOGLU SADIK.DİŞEL UMUT.MERTSOYLU HÜSEYİN,BESEN ALI AYBERK,KARADENİZ CEMİLE, SÜMBÜL AHMET TANER.ABALI HÜSEYİN,ÖZYILKAN ÖZGÜR
  • Effectiveness of percutaneous metal stent placement in cholangiocarcinoma patients with midterm follow-up: Single center experience European Journal of Radiology, 81(8), 1724-1727., Number of Citation: 3, Doi: 10.1016/j.ejrad.2011.04.056 KÖSE FATİH,OGUZKURT LEVENT.BESEN ALI AYBERK.SÜMBÜL AHMET TANER,SEZER AHMET, Karadeniz Cemile.DİŞEL UMUT.MERTSOYLU HÜSEYİN,ÖZYILKAN ÖZGÜR
  • A case report of bevacizumab-related osteonecrosis of the jaw: Old problem, new culprit. Oral Oncology, 48(2), 2-3., Number of Citation: 13, Doi: 10.1016/j.oraloncology.2011.07.030, DİŞEL UMUT.Beşen Ali Ayberk.Beşen Ali Ayberk.ÖZYILKAN ÖZGÜR.Er Efsun,CANPOLAT EMİNE TUBA
  • Secondary malignancy after imatinib therapy: eight cases and review of the literature Leukemia & Lymphoma, 53(9), 1706¬1708., Number of Citation: 7, Doi: 10.3109/10428194.2012.666545 BOZKURT DUMAN BERNA.PAYDAŞ SEMRA.DİŞEL UMUT BESEN AYBERK,GÜRKAN EMEL
  • Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: The Başkent University experience. Asian Pacific Journal of Cancer Prevention, 12(5), 1185-1188., Number of Citations: 1 KÖSE FATİH,BESEN ALI AYBERK.SÜMBÜL AHMET TANER,SEZER AHMET.KARADENIZ CEMİLE, DİŞEL UMUT.ALTUNDAG ÖZDEN,ÖZYILKAN ÖZGÜR
  • Hypertension Associated With Angiogoenesis Inhibitors: What Do Oncologists Really Do in Daily Routine? A Small Survey The Journal of Clinical Hypertension, 13(11), 863-863., Citation: 0, Doi: 10.1111 /j.1751-7176.2011.00526. DİŞEL UMUT.ABALI HÜSEYİN.SÜMBÜL AHMET TANER.ÖZYILKAN ÖZGÜR
  • Letter to the editor. Supportive Care in Cancer 18(6), 657-658., Citation: 0, Doi: 10.1007/s00520-010- 0842-9, KÖSE FATİH.Abali Huseyin.Ayberk Besen,DİŞEL UM UT, HAYRAN KADİR MUTLU
  • Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine Cutaneous and Ocular Toxicology, 29(2), 140-142., Number of Citation: 5, Doi: 10.3109/15569521003699585 DİŞEL UMUT.GURKUT OZLEM.ABALI HÜSEYİN.KALEAĞASI ŞÜKRÜ HAKAN,MERTSOYLU HÜSEYİN, ÖZYILKAN ÖZGÜR.Muhammad Wasif Saif
  • Severe Pulmonary Toxicity Associated with Fludarabine and Possible Contribution of Rituximab. Chemotherapy, 56(2), 89- 93., Citation Count: 5, Doi: 10.1159/000305255, DİŞEL UMUT.PAYDAŞ SEMRA,YAVUZ SİNAN,KARAKOÇ EMRE
Good to Know

Frequently Asked Questions

What is Dr. Umut Dişel's specialty?
Dr. Umut Dişel is a specialist in Internal Medicine at Acibadem. For a personalised assessment, the Acibadem international patient team can review your medical history and reports and explain the suitable next steps.
Which hospital does Dr. Umut Dişel practise at?
Dr. Umut Dişel sees patients at Acibadem Adana Hospital in Adana. The international patient team can confirm current availability and help you plan a consultation or visit.
What languages can I use when consulting Dr. Umut Dişel?
Consultations with Dr. Umut Dişel are supported in Turkish and English. In addition, Acibadem provides multilingual coordination and interpreter support so international patients can communicate clearly throughout their care.
How can I book an appointment with Dr. Umut Dişel?
You can request an appointment with Dr. Umut Dişel using the appointment form on this page, or by contacting the Acibadem international patient team by phone or WhatsApp. After you share your details, the team checks availability and confirms your appointment, usually within 24 hours.
Is an online video consultation available with Dr. Umut Dişel?
Yes. Dr. Umut Dişel offers online video consultations, so you can discuss your condition and reports with the specialist before making any travel arrangements. The international patient team can help you schedule a secure video visit.
Can international patients arrange treatment with Dr. Umut Dişel?
Yes. Acibadem supports international patients end to end — from the first consultation and treatment planning through appointment scheduling, interpretation during the stay and follow-up after returning home. Sharing your case for an initial assessment is free of charge.
How do I get a second opinion involving Dr. Umut Dişel?
You can request an independent review of your diagnosis and proposed treatment. Share your medical reports through the consultation or "Ask a Doctor" form on this site, and the team will arrange a specialist review and explain the available options.
Care without borders

A dedicated team, from first message to follow-up

Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.

Book an Appointment

Schedule your appointment with Assoc. Prof. Dr. Umut Dişel

Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.

  1. 1
    Choose your date & timePick a preferred day and time slot for your visit.
  2. 2
    Share your detailsTell us how to reach you and anything we should know.
  3. 3
    We confirm with youOur team confirms the appointment by phone or email.
Why patients choose Acıbadem
35+Years of expertise
90+Countries served
20+Languages spoken
24/7Patient support
Prefer to talk now?
Appointment Request

Request your appointment

This request goes directly to this doctor’s schedule.

Assoc. Prof. Dr. Umut Dişel Appointment with Umut Dişel Internal Medicine

Your information stays strictly confidential and is used only to arrange your care.

Where

Hospitals

Departments

Medical Units

Treatments

Treatments Performed

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.